Sant'Andrea Hospital, La Spezia, ASL5 Liguria
- Address
- Via Fazio 30, 19121 La Spezia, Italy
Sant'Andrea Hospital, La Spezia - Cardiovascular Research Center
Sant'Andrea Hospital in La Spezia serves as a specialized cardiovascular research facility within the ASL5 Liguria health system, focusing on advanced interventional cardiology and acute coronary syndrome management. The center demonstrates particular expertise in the treatment and long-term management of patients experiencing acute myocardial infarction requiring percutaneous coronary intervention.
- Acute myocardial infarction management and intervention strategies
- PCSK9 inhibitor therapies for lipid management in post-MI patients
- Real-world cardiovascular outcomes research and guideline implementation
The research program emphasizes practical, real-world approaches to achieving LDL cholesterol targets in high-risk populations, particularly those with recent STEMI and NSTEMI. Through participation in multicenter trials, Sant'Andrea Hospital contributes to advancing evidence-based strategies for reducing cardiovascular mortality and unplanned hospitalizations in acute coronary syndrome patients, bridging the gap between clinical guidelines and everyday practice.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sant'Andrea Hospital, La Spezia, ASL5 Liguria
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Evolocumab Versus Standard Care in LDL-C Reduction for Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Sep 2021 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Evolocumab | 1 | Unknown | 2021-09-29 | 2021-09-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.